286 related articles for article (PubMed ID: 34043485)
1. Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis.
Zhang Y; Chen X; Cao Y; Yang Z
Bioengineered; 2021 Dec; 12(1):2074-2086. PubMed ID: 34043485
[TBL] [Abstract][Full Text] [Related]
2. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
He X; Li J; Wu J; Zhang M; Gao P
Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
[TBL] [Abstract][Full Text] [Related]
3. APOBEC3-induced mutation of the hepatitis virus B DNA genome occurs during its viral RNA reverse transcription into (-)-DNA.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Patterson AP
J Biol Chem; 2021 Aug; 297(2):100889. PubMed ID: 34181944
[TBL] [Abstract][Full Text] [Related]
4. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
5. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.
Vartanian JP; Henry M; Marchio A; Suspène R; Aynaud MM; Guétard D; Cervantes-Gonzalez M; Battiston C; Mazzaferro V; Pineau P; Dejean A; Wain-Hobson S
PLoS Pathog; 2010 May; 6(5):e1000928. PubMed ID: 20523896
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs associated with HBV infection and HBV-related HCC.
Xie KL; Zhang YG; Liu J; Zeng Y; Wu H
Theranostics; 2014; 4(12):1176-92. PubMed ID: 25285167
[TBL] [Abstract][Full Text] [Related]
7. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
8. HBV triggers APOBEC2 expression through miR‑122 regulation and affects the proliferation of liver cancer cells.
Li A; Wu J; Zhai A; Qian J; Wang X; Qaria MA; Zhang Q; Li Y; Fang Y; Kao W; Song W; Zhang Z; Zhang F
Int J Oncol; 2019 Nov; 55(5):1137-1148. PubMed ID: 31485598
[TBL] [Abstract][Full Text] [Related]
9. The role of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma.
Moyo B; Nicholson SA; Arbuthnot PB
Virus Res; 2016 Jan; 212():103-13. PubMed ID: 26239319
[TBL] [Abstract][Full Text] [Related]
10. Complex interactions between microRNAs and hepatitis B/C viruses.
Fan HX; Tang H
World J Gastroenterol; 2014 Oct; 20(37):13477-92. PubMed ID: 25309078
[TBL] [Abstract][Full Text] [Related]
11. Human APOBEC3 Variations and Viral Infection.
Sadeghpour S; Khodaee S; Rahnama M; Rahimi H; Ebrahimi D
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372572
[TBL] [Abstract][Full Text] [Related]
12. Possible Involvement of Multidrug-Resistant Hepatitis B Virus sW172* Truncation Variant in the ER Stress Signaling Pathway during Hepatocarcinogenesis.
Zheng J; Jiang S; Lu F
Jpn J Infect Dis; 2016 Jul; 69(4):306-13. PubMed ID: 26567840
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.
Xia Y; Cheng X; Li Y; Valdez K; Chen W; Liang TJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021897
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma.
Deng M; Hou J; Hu J; Wang S; Chen M; Chen L; Ju Y; Li C; Meng S
Cancer Lett; 2016 Dec; 383(1):62-72. PubMed ID: 27693636
[TBL] [Abstract][Full Text] [Related]
15. Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma.
Deng Y; Du Y; Zhang Q; Han X; Cao G
Cancer Lett; 2014 Feb; 343(2):161-71. PubMed ID: 24120759
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus-induced hepatocellular carcinoma.
Xu C; Zhou W; Wang Y; Qiao L
Cancer Lett; 2014 Apr; 345(2):216-22. PubMed ID: 23981576
[TBL] [Abstract][Full Text] [Related]
17. Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular Carcinoma.
Samudh N; Shrilall C; Arbuthnot P; Bloom K; Ely A
Front Immunol; 2022; 13():834650. PubMed ID: 35154157
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
Bonvin M; Greeve J
Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
[TBL] [Abstract][Full Text] [Related]
19. The inhibition of hepatitis B virus by APOBEC cytidine deaminases.
Janahi EM; McGarvey MJ
J Viral Hepat; 2013 Dec; 20(12):821-8. PubMed ID: 24304451
[TBL] [Abstract][Full Text] [Related]
20. The Antiresection Activity of the X Protein Encoded by Hepatitis Virus B.
Ren L; Zeng M; Tang Z; Li M; Wang X; Xu Y; Weng Y; Wang X; Wang H; Guo L; Zuo B; Wang X; Wang S; Lou J; Tang Y; Mu D; Zheng N; Wu X; Han J; Carr AM; Jeggo P; Liu C
Hepatology; 2019 Jun; 69(6):2546-2561. PubMed ID: 30791110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
